Literature DB >> 11588306

Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination.

W J Jones1, L S Williams, J F Meschia.   

Abstract

BACKGROUND AND
PURPOSE: The Questionnaire for Verifying Stroke-Free Status (QVSFS) is an 8-item structured interview designed to identify stroke-free individuals. Previously, the QVSFS was validated with medical record review in a cohort with a low prevalence (7.1%) of stroke or transient ischemic attack (TIA). The objective of this study was to evaluate the validity of the QVSFS by comparing it with stroke status as determined by neurological history and examination in a population with a higher prevalence of stroke.
METHODS: A research assistant administered the QVSFS to outpatients from Veterans Administration stroke and general medicine clinics. Subjects were defined as QVSFS negative if responses to all 8 questions were negative. Questions requiring rephrasing or clarification were noted. Neurologists, blinded to QVSFS scores, interviewed and examined all subjects to determine stroke-free status, defined as no history or examination findings of previous stroke and/or TIA.
RESULTS: One hundred fifty-five subjects were examined; mean age was 70 years; 98.1% were male. Seventy-eight subjects were determined to be stroke free by the neurologist. The negative predictive value of the QVSFS was 0.96, with positive predictive value of 0.71. No question required rephrasing or clarification >5 times. Twenty-two subjects (14.2%) required rephrasing or clarification of at least 1 question.
CONCLUSIONS: The QVSFS can effectively identify stroke-free individuals with a high degree of accuracy, even in a population with a large proportion of patients with prior stroke or TIA. Accuracy for identifying subjects with stroke and/or TIA is lower, but the QVSFS may still be useful as a screening tool in that regard.

Entities:  

Mesh:

Year:  2001        PMID: 11588306     DOI: 10.1161/hs1001.096191

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  67 in total

1.  Identifying a high stroke risk subgroup in individuals with heart failure.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-03       Impact factor: 2.136

2.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

3.  What stroke symptoms tell us: association of risk factors and individual stroke symptoms in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Liyan Gao; James F Meschia; Suzanne E Judd; Paul Muntner; Leslie A McClure; Virginia J Howard; James D Rhodes; Mary Cushman; Monika M Safford; Elsayed Z Soliman; Dawn O Kleindorfer; George Howard
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-07       Impact factor: 2.136

4.  Silent new ischemic lesions after index stroke and the risk of future clinical recurrent stroke.

Authors:  Dong-Wha Kang; Moon-Ku Han; Hye-Jin Kim; Hoyon Sohn; Bum Joon Kim; Sun U Kwon; Jong S Kim; Steven Warach
Journal:  Neurology       Date:  2015-12-18       Impact factor: 9.910

5.  The impact of privacy protections on recruitment in a multicenter stroke genetics study.

Authors:  D T Chen; B B Worrall; R D Brown; T G Brott; B M Kissela; T S Olson; S S Rich; J F Meschia
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

6.  The effect of feedback schedule manipulation on speech priming patterns and reaction time.

Authors:  Dana Slocomb; Kristie A Spencer
Journal:  J Psycholinguist Res       Date:  2008-09-12

7.  Prevalence and significance of stroke symptoms among patients receiving maintenance dialysis.

Authors:  Manjula Kurella Tamura; Jaclyn Biada Meyer; Anjali B Saxena; J W Terri Huh; Virginia G Wadley; Brigitte Schiller
Journal:  Neurology       Date:  2012-08-08       Impact factor: 9.910

8.  N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort.

Authors:  Mary Cushman; Suzanne E Judd; Virginia J Howard; Brett Kissela; Orlando M Gutiérrez; Nancy S Jenny; Ali Ahmed; Evan L Thacker; Neil A Zakai
Journal:  Stroke       Date:  2014-04-22       Impact factor: 7.914

9.  Quality of life after intra-arterial therapy for acute ischemic stroke.

Authors:  Melissa M Cortez; Michael J Wilder; Molly McFadden; Jennifer J Majersik
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-05-09       Impact factor: 2.136

10.  Multilingual Validation of the Questionnaire for Verifying Stroke-Free Status in West Africa.

Authors:  Fred Sarfo; Mulugeta Gebregziabher; Bruce Ovbiagele; Rufus Akinyemi; Lukman Owolabi; Reginald Obiako; Onoja Akpa; Kevin Armstrong; Albert Akpalu; Sheila Adamu; Vida Obese; Nana Boa-Antwi; Lambert Appiah; Oyedunni Arulogun; Yaw Mensah; Abiodun Adeoye; Aridegbe Tosin; Osimhiarherhuo Adeleye; Eric Tabi-Ajayi; Ibinaiye Phillip; Abubakar Sani; Suleiman Isah; Nasir Tabari; Aliyu Mande; Atinuke Agunloye; Godwin Ogbole; Joshua Akinyemi; Ruth Laryea; Sylvia Melikam; Ezinne Uvere; Gregory Adekunle; Salaam Kehinde; Paschal Azuh; Abdul Dambatta; Naser Ishaq; Raelle Saulson; Donna Arnett; Hemnant Tiwari; Carolyn Jenkins; Dan Lackland; Mayowa Owolabi
Journal:  Stroke       Date:  2015-11-17       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.